RPS-BLAST 2.2.26 [Sep-21-2011]
Database: CDD.v3.10
44,354 sequences; 10,937,602 total letters
Searching..................................................done
Query= psy594
(218 letters)
>gnl|CDD|212094 cd11556, SLC6sbd_SERT-like_u1, uncharacterized subgroup of the
SERT-like Na(+)- and Cl(-)-dependent monoamine
transporter subfamily; solute binding domain. SERT-like
Na(+)- and Cl(-)-dependent monoamine transporters,
transport monoamine neurotransmitters from synaptic
spaces into presynaptic neurons. Members include: the
norepinephrine transporter NET, the serotonin
transporter SERT , and the dopamine transporter DAT1.
These latter may play a role in diseases or disorders
including depression, anxiety disorders, and
attention-deficit hyperactivity disorder, and in the
control of human behavior and emotional states. They
belongs to the solute carrier 6 (SLC6) transporter
family. Members of this subgroup are uncharacterized.
Length = 552
Score = 141 bits (358), Expect = 2e-39
Identities = 81/235 (34%), Positives = 101/235 (42%), Gaps = 86/235 (36%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMA-------------- 46
ML VGGIPLFYMELALGQ++RKGAIT WGRI PLFKG + +A
Sbjct: 46 MLVVGGIPLFYMELALGQYYRKGAITSWGRICPLFKGIGYAVVLIAFYVDFFYNVIIAWS 105
Query: 47 ---------------------------SLTWPPALFIDGKYFNGLLSGVLVLTQHLNG-- 77
W + + N S ++
Sbjct: 106 LYYFFASFTFNLPWTSCNNSWNTPNCYEPHWSEDGTVPCRSANQSFSA-TNISAAEENFT 164
Query: 78 -------NRYILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK------ 124
R +LE+ S G+ DLG I+W + LCL AVYLICYFS+WKGI TSGK
Sbjct: 165 SAALEYFERGVLELHVSRGVTDLGNIRWQILLCLFAVYLICYFSLWKGIHTSGKVVWFTA 224
Query: 125 ----------------------GIKYYLQPNFDAITKSEVSGDTS-------GPG 150
GI+YYL+PNF+A+ +EV D + GPG
Sbjct: 225 LFPYVVLFILLIRGVTLPGSQNGIEYYLRPNFEALKSAEVWVDAATQVFFSLGPG 279
Score = 108 bits (271), Expect = 2e-27
Identities = 44/53 (83%), Positives = 50/53 (94%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
T GPGLVF+VYP A++TMPGS FWSL+FF+ML+TLGLDSSFGGSEAIITALSD
Sbjct: 338 TEGPGLVFVVYPEALSTMPGSTFWSLLFFLMLMTLGLDSSFGGSEAIITALSD 390
>gnl|CDD|215790 pfam00209, SNF, Sodium:neurotransmitter symporter family.
Length = 506
Score = 108 bits (273), Expect = 1e-27
Identities = 56/198 (28%), Positives = 83/198 (41%), Gaps = 61/198 (30%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMAS---------LTWP 51
L GIPLF++ELALGQ+ R+GAI W +I PLFKG + + W
Sbjct: 46 FLITAGIPLFFLELALGQYTREGAIGVWRKICPLFKGIGYASMVIVFYIGIYYNVIIAW- 104
Query: 52 PALFIDGKYFNGLLSGVLVLTQHLNG----------------NRYILEMQHSTGLHDLGY 95
AL+ Y + L N R +L++ S G+ DLG
Sbjct: 105 -ALY----YLFSSFTTELPWASCNNSWNTPRCEKTSPVEEFWERKVLKL--SDGIEDLGG 157
Query: 96 IKWDMALCLLAVYLICYFSMWKGISTSGK----------------------------GIK 127
++W + LCLL +++ YF +WKG+ +SGK GI
Sbjct: 158 LRWPLTLCLLVAWVVVYFCIWKGVKSSGKVVYFTATFPYVVLLVLLVRGVTLPGAADGID 217
Query: 128 YYLQPNFDAITKSEVSGD 145
+YL P++ + +V D
Sbjct: 218 FYLTPDWSKLLDPQVWID 235
Score = 86.2 bits (214), Expect = 1e-19
Identities = 35/52 (67%), Positives = 41/52 (78%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
SGPGL FI YP A+ +P S FWS++FF+ML+TLGLDS FGG E IITAL D
Sbjct: 307 SGPGLAFIAYPEAVTMLPLSPFWSVLFFLMLITLGLDSQFGGVEGIITALVD 358
>gnl|CDD|212066 cd11497, SLC6sbd_SERT-like, Na(+)- and Cl(-)-dependent monoamine
transporters, SERT, NET, DAT1 and related proteins;
solute binding domain. This subgroup represents the
solute-binding domain of transmembrane transporters that
transport monoamine neurotransmitters from synaptic
spaces into presynaptic neurons. Members include: NET
which transports norepinephrine, SERT which transports
serotonin, and DAT1 which transports dopamine. These
transporters may play a role in diseases including
depression, anxiety disorders, attention-deficit
hyperactivity disorder, and in the control of human
behavior and emotional states. This subgroup belongs to
the solute carrier 6 (SLC6) transporter family.
Length = 539
Score = 104 bits (262), Expect = 4e-26
Identities = 40/53 (75%), Positives = 47/53 (88%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
T GPGLVFIVYP AIAT+PGS FW++IFF+ML+TLGLDS+FGG EA+IT L D
Sbjct: 324 TEGPGLVFIVYPEAIATLPGSTFWAIIFFLMLITLGLDSTFGGLEAVITGLCD 376
Score = 91.2 bits (227), Expect = 2e-21
Identities = 36/93 (38%), Positives = 48/93 (51%), Gaps = 28/93 (30%)
Query: 78 NRYILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK------------- 124
R +LE+Q S G+ DLG KW +ALCL AV++I YFS+WKG+ +SGK
Sbjct: 158 ERKVLELQKSEGIDDLGGPKWQLALCLFAVFIIVYFSLWKGVKSSGKVVWVTATMPYVVL 217
Query: 125 ---------------GIKYYLQPNFDAITKSEV 142
GIKYYL PN+ + +V
Sbjct: 218 SILLIRGLTLPGASDGIKYYLTPNWSKLKDPKV 250
Score = 77.0 bits (190), Expect = 2e-16
Identities = 26/37 (70%), Positives = 30/37 (81%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
ML GG+PLFYMELALGQ+HR G IT W +I P+FKG
Sbjct: 46 MLIFGGLPLFYMELALGQYHRSGCITVWRKICPIFKG 82
>gnl|CDD|212065 cd11496, SLC6sbd-TauT-like, Na(+)- and Cl(-)-dependent taurine
transporter TauT, and related proteins; solute-binding
domain. This subgroup represents the solute-binding
domain of TauT-like Na(+)- and Cl(-)-dependent
transporters. Family members include: human TauT which
transports taurine, human GAT1, GAT2, and GAT3, and
BGT1, which transport gamma-aminobutyric acid (GABA),
and human CT1 which transports creatine. This subgroup
belongs to the solute carrier 6 (SLC6) transporter
family.
Length = 543
Score = 92.6 bits (231), Expect = 6e-22
Identities = 56/210 (26%), Positives = 89/210 (42%), Gaps = 74/210 (35%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG----KMTRLARMAS-----LTWPP 52
L + GIP+F++E+ALGQ+ +G IT W +I PLFKG + + L W
Sbjct: 47 LVLCGIPIFFLEVALGQYTSQGGITAW-KICPLFKGIGYASAVIVFWLNIYYIVILAW-- 103
Query: 53 ALF------------------------IDGKYFNGLLSGVLVLTQHLNG--------NRY 80
ALF ++ N L + + + N R
Sbjct: 104 ALFYLFNSFTSELPWTTCDNWWNTECCVETYSNNNLSNLTKNCSNNTNSTSPVEEFWERR 163
Query: 81 ILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK---------------- 124
+L + S G+ D+G I+W++ALCLL ++ICYF +WKG+ ++GK
Sbjct: 164 VLGI--SDGIEDIGSIRWELALCLLLAWIICYFCIWKGVKSTGKVVYFTATFPYVMLIIL 221
Query: 125 ------------GIKYYLQPNFDAITKSEV 142
GI +YL+P+ + +V
Sbjct: 222 LIRGVTLPGASDGIYFYLKPDLTKLLDPQV 251
Score = 82.2 bits (204), Expect = 2e-18
Identities = 28/52 (53%), Positives = 37/52 (71%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
SGPGL FI YP A++ +P W+++FF+MLL LGLDS F G E +TA+ D
Sbjct: 326 SGPGLAFIAYPRAVSLLPLPQLWAVLFFIMLLLLGLDSQFVGVEGFVTAIVD 377
>gnl|CDD|212082 cd11513, SLC6sbd_SERT, Na(+)- and Cl(-)-dependent serotonin
transporter SERT; solute-binding domain. SERT (also
called 5-HTT), is a transmembrane transporter that
transports the neurotransmitter serotonin from synaptic
spaces into presynaptic neurons. The antiport of a K+
ion is believed to follow the transport of serotonin and
promote the reorientation of SERT for another transport
cycle. Human SERT is encoded by the SLC6A4 gene. SERT is
expressed in brain, peripheral nervous system, placenta,
epithelium, and platelets. SERT may play a role in
diseases or disorders including anxiety, depression,
autism, gastrointestinal disorders, premature
ejaculation, and obesity. It may also have a role in
social cognition. This subgroup belongs to the solute
carrier 6 (SLC6) transporter family.
Length = 537
Score = 86.8 bits (215), Expect = 7e-20
Identities = 32/53 (60%), Positives = 43/53 (81%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+GP L+FI Y AIA MPGS F+++IFF+M++TLGLDS+FGG E +ITA+ D
Sbjct: 322 DAGPSLLFITYAEAIANMPGSTFFAIIFFLMIITLGLDSTFGGLEGVITAVLD 374
Score = 68.7 bits (168), Expect = 1e-13
Identities = 36/107 (33%), Positives = 52/107 (48%), Gaps = 35/107 (32%)
Query: 79 RYILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK-------------- 124
R++L++ STGL DLG I W +ALCL ++ I YFS+WKG+ TSGK
Sbjct: 156 RHVLQVHRSTGLGDLGGISWQLALCLFLIFTIVYFSIWKGVKTSGKVVWVTATFPYIVLF 215
Query: 125 --------------GIKYYLQPNFDAITKSEVSGDTS-------GPG 150
G+ YYL+P + + ++ V D + GPG
Sbjct: 216 ILLIRGATLPGAWRGVVYYLKPKWHKLLETGVWVDAAAQIFFSLGPG 262
Score = 65.2 bits (159), Expect = 2e-12
Identities = 25/37 (67%), Positives = 29/37 (78%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
M GGIPLFYMELALGQ+HR G I+ W +I P+FKG
Sbjct: 46 MAIFGGIPLFYMELALGQYHRTGCISIWRKICPIFKG 82
>gnl|CDD|212034 cd10324, SLC6sbd, Solute carrier 6 family, neurotransmitter
transporters; solute-binding domain. This family
represents the solute-binding domain of SLC6 proteins
(also called the sodium- and chloride-dependent
neurotransmitter transporter family or Na+/Cl--dependent
transporter family). These use sodium and chloride
electrochemical gradients to catalyze the
thermodynamically uphill movement of a variety of
substrates, and include neurotransmitter transporters
(NTTs). The latter are Na+/Cl--dependent plasma membrane
transporters for the monoamine neurotransmitters
serotonin (5-hydroxytryptamine), dopamine, and
norepinephrine, and the amino acid neurotransmitters
GABA and glycine. NTTs are widely expressed in the
mammalian brain, and are involved in regulating
neurotransmitter signaling and homeostasis, through
facilitating the uptake of released neurotransmitters
from the extracellular space into neurons and glial
cells. NTTs are the target of a range of therapeutic
drugs for the treatment of psychiatric diseases, such as
major depression, anxiety disorders, attention deficit
hyperactivity disorder and epilepsy. In addition, they
are the primary targets of cocaine, amphetamines and
other psychostimulants. This family also includes
Drosophila Blot which is expressed primarily in
epithelial tissues of ectodermal origin and in the
nervous system of the embryo and larvae, but in addition
found in the developing oocyte and the freshly laid egg.
A lack or reduction of Blot function during oogenesis
results in early arrest of embryonic development. 12
transmembrane helices (TMs) appears to be common for
eukaryotic and some prokaryotic and archaeal SLC6s, (a
core inverted topology repeat, TM1-5 and TM6-10, plus
TMs11-12; TMs numbered to conform to the SLC6 Aquifex
aeolicus LeuT), although a majority of bacterial, and
some archaeal SLC6s lack TM12, for example the
functional Fusobacterium nucleatum tyrosine transporter
Tyt1.
Length = 417
Score = 86.4 bits (215), Expect = 8e-20
Identities = 31/59 (52%), Positives = 36/59 (61%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPR 204
GPGL F+VYP AIA MP WS++FF ML LGLDS F E I+TA+ D R
Sbjct: 261 KGGPGLAFVVYPEAIAKMPVPQLWSVLFFFMLFLLGLDSQFAIVETIVTAIVDEFPKLR 319
Score = 77.5 bits (192), Expect = 8e-17
Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 55/170 (32%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
ML + GIPLF++ELALGQ+ +G + + RI PLFKG A++ F+ Y
Sbjct: 45 MLLLVGIPLFFLELALGQYTSRGPVGAFWRICPLFKG--VGYAQVV------ISFLVAIY 96
Query: 61 FNGLLSGVLVLTQHLNGNRYILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGIS 120
+N +++ L Y+ S +I W++ALCLL +++ Y ++KG+
Sbjct: 97 YNVIIAWTL---------YYLF---AS-------FINWELALCLLLAWILVYLCIFKGVK 137
Query: 121 TSGK----------------------------GIKYYLQPNFDAITKSEV 142
+SGK GI Y+L P++ + +V
Sbjct: 138 SSGKVVYFTATFPYVVLFILLIRGVTLPGAGDGILYFLTPDWSKLLDPKV 187
>gnl|CDD|212081 cd11512, SLC6sbd_NET, Na(+)- and Cl(-)-dependent norepinephrine
transporter NET; solute-binding domain. NET (also
called NAT1, NET1), is a transmembrane transporter that
transports the neurotransmitter norepinephrine from
synaptic spaces into presynaptic neurons. Human NET is
encoded by the SLC6A2 gene. NET is expressed in brain,
peripheral nervous system, adrenal gland, and placenta.
NET may play a role in diseases or disorders including
depression, orthostatic intolerance, anorexia nervosa,
cardiovascular diseases, alcoholism, and
attention-deficit hyperactivity disorder. This subgroup
belongs to the solute carrier 6 (SLC6) transporter
family.
Length = 560
Score = 84.6 bits (209), Expect = 5e-19
Identities = 55/169 (32%), Positives = 75/169 (44%), Gaps = 55/169 (32%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMA-------------SL 48
L + G+PLFYMELALGQ++R+GA T W +I P FKG + +A SL
Sbjct: 47 LIIAGMPLFYMELALGQYNREGAATVW-KICPCFKGVGYAVILIALYVGFYYNVIIAWSL 105
Query: 49 ------------------TWPPALFIDGKYFNGLLSGVLVLTQHLNGNRY---------- 80
W D K N + G NG +Y
Sbjct: 106 YYLFSSFTSELPWTTCGNVWNSPNCTDPKLLNASVLG--------NGTKYSKYKLTPAAE 157
Query: 81 -----ILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+L + S G+HDLG +W + LCL V ++ +FS+WKG+ TSGK
Sbjct: 158 FYERGVLHLHESAGIHDLGLPRWQLTLCLFVVVIVLFFSLWKGVKTSGK 206
Score = 80.8 bits (199), Expect = 1e-17
Identities = 35/53 (66%), Positives = 45/53 (84%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
T G GLVFI+YP AI+T+ GS FW+++FF+MLLTLG+DSS GG EA+IT L+D
Sbjct: 326 TEGAGLVFILYPEAISTLSGSTFWAVVFFIMLLTLGIDSSMGGMEAVITGLAD 378
>gnl|CDD|212069 cd11500, SLC6sbd_PROT, Na(+)- and Cl(-)-dependent L-proline
transporter PROT; solute-binding domain. PROT is a
high-affinity L-proline transporter that transports
L-proline, and may have a role in excitatory
neurotransmission. Human PROT is encoded by the SLC6A7
gene, a potential susceptible gene for asthma. PROT is
expressed in the brain. This subgroup belongs to the
solute carrier 6 (SLC6) transporter family.
Length = 544
Score = 80.6 bits (199), Expect = 1e-17
Identities = 55/206 (26%), Positives = 86/206 (41%), Gaps = 65/206 (31%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG--------------------KMT 40
ML GIPLF+MEL+LGQ+ G +T W + P+FKG T
Sbjct: 46 MLAFCGIPLFFMELSLGQYGSLGPLTVW-KCCPIFKGIGYGMLLVSGLVCIYYNVIIAWT 104
Query: 41 RLARMASLTWPPALFIDGKYFNGLLSGVLVLTQHLNG----------------NRYILEM 84
AS T G ++N + ++ NR +L +
Sbjct: 105 LFYLFASFTSVLPWEHCGNWWNTESCLEHRVKDNMGALPVNLTRTVSPSEEYWNRRVLGI 164
Query: 85 QHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK-------------------- 124
Q S+G+ D G ++W++ALCLL ++I +F ++KG+ +SGK
Sbjct: 165 QGSSGIGDPGEVRWELALCLLLAWVIVFFCLFKGVKSSGKVVYFTATFPYIILIVLLVRG 224
Query: 125 --------GIKYYLQPNFDAITKSEV 142
GI++YL P+F + S+V
Sbjct: 225 VTLEGALKGIQFYLTPDFHRLASSQV 250
Score = 75.2 bits (185), Expect = 7e-16
Identities = 30/52 (57%), Positives = 39/52 (75%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+GPGL F+ YP A+ +P S FWS++FF MLLTLGLDS F E I+TA++D
Sbjct: 325 AGPGLAFVAYPEALTLLPVSPFWSILFFFMLLTLGLDSQFAMLETIVTAVTD 376
>gnl|CDD|212080 cd11511, SLC6sbd_BGT1, Na(+)- and Cl(-)-dependent betaine/GABA
transporter-1, and related proteins; solute-binding
domain. BGT1 is a relatively low-affinity transporter
of gamma-aminobutyric acid (GABA), and can also
transport betaine. GABA is the main inhibitory
neurotransmitter within the mammalian CNS. Human BGT1 is
encoded by the SLC6A12 gene, and is similar to mouse
GAT2. Mouse GAT2 plays a role in transporting GABA
across the blood-brain barrier. In addition to being
expressed in cells of the central nervous system, BGT1
is expressed in peripheral tissues, including kidney,
liver, and heart. An association has been shown between
the SLC6A12 gene and the occurrence of
aspirin-intolerant asthma, and BGT1 is a drug target for
antiepileptic drugs. This subgroup belongs to the solute
carrier 6 (SLC6) transporter family.
Length = 541
Score = 79.2 bits (195), Expect = 3e-17
Identities = 50/158 (31%), Positives = 76/158 (48%), Gaps = 37/158 (23%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG---------KMTRLARMASLTWPP 52
LF GIPLF++E ALGQ+ +G +T W +I P+F+G + + L+W
Sbjct: 48 LFTCGIPLFFLETALGQYTSQGGVTAWRKICPIFEGIGYASQVIESYLNVYYIIILSW-- 105
Query: 53 ALFIDGKYFNGLL--------------------SGVLVLTQHLNGNRYILEMQH------ 86
ALF F +L SG T N ++E
Sbjct: 106 ALFYLFSSFTSVLPWATCNNPWNSDLCVDFLNHSGADNRTPPENATSPVMEFWEKRVLGL 165
Query: 87 STGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+ G+H LG ++W++ALCLL ++ICYF +WKG+ ++GK
Sbjct: 166 TDGIHKLGTVRWELALCLLLAWIICYFCIWKGVKSTGK 203
Score = 62.6 bits (152), Expect = 1e-11
Identities = 29/52 (55%), Positives = 36/52 (69%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
SGPGL FI YP A+ MP S WS +FF+ML+ LGLDS F E+++TA D
Sbjct: 324 SGPGLAFIAYPTAVTMMPVSQLWSCLFFLMLIFLGLDSQFVCVESMVTASID 375
>gnl|CDD|212083 cd11514, SLC6sbd_DAT1, Na(+)- and Cl(-)-dependent dopamine
transporter 1; solute-binding domain. DAT1 (also called
DAT), is a plasma membrane transport protein that
functions at the dopaminergic synapses to transport
dopamine from the extracellular space back into the
presynaptic nerve terminal. Human DAT1 is encoded by the
SLC6A3 gene, and is expressed in the brain. DAT1 may
play a role in diseases or disorders related to
dopaminergic neurons, including attention-deficit
hyperactivity disorder (ADHD), Tourette syndrome,
Parkinson's disease, alcoholism, drug abuse,
schizophrenia, extraversion, and risky behavior. This
subgroup belongs to the solute carrier 6 (SLC6)
transporter family.
Length = 555
Score = 79.2 bits (195), Expect = 3e-17
Identities = 33/53 (62%), Positives = 43/53 (81%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
GPGL+FI+YP AIAT+P S W++IFF+MLLTLG+DS+ GG E++IT L D
Sbjct: 325 KDGPGLIFIIYPEAIATLPLSSVWAVIFFIMLLTLGIDSAMGGMESVITGLID 377
Score = 69.2 bits (169), Expect = 8e-14
Identities = 49/160 (30%), Positives = 70/160 (43%), Gaps = 38/160 (23%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVP---------------------------- 33
+ + G+PLFYMELALGQF+R+GA W +I P
Sbjct: 47 MVIAGMPLFYMELALGQFNREGAAGVW-KICPIFKGVGFTVILISLYVGFFYNVIIAWAL 105
Query: 34 --LFKGKMTRLARM-ASLTW-----PPALFIDGKYFNGLLSGVLVLTQHLNG-NRYILEM 84
LF L + + +W A D + L+ T R +L +
Sbjct: 106 FYLFSSFTGELPWIHCNNSWNSPNCSDAHPGDSSGDSSGLNDTYKTTPAAEYFERGVLHL 165
Query: 85 QHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
S G+HDLG +W + CL+ V ++ YFS+WKG+ TSGK
Sbjct: 166 HESHGIHDLGPPRWQLTSCLVVVIVLLYFSLWKGVKTSGK 205
>gnl|CDD|212040 cd10332, SLC6sbd-B0AT-like, System B(0) neutral amino acid
transporter AT1, 2 and 3, and related proteins;
solute-binding domain. This subgroup includes the
solute-binding domain of transmembrane transporters,
which transport, i) neutral amino acids: NTT4 (also
called XT1), SBAT1 (also called B0AT2, v7-3, NTT7-3),
and B0AT1 (also called HND); the human genes encoding
these are SLC6A17, SLC6A15, and SLC6A19 respectively,
ii) glycine: B0AT3 (also called Xtrp2, XT2), iii) imino
acids, such as proline, pipecolate, MeAIB, and
sarcosine: SIT1 (also called XTRP3, XT3, IMINO). The
human genes encoding B0AT3 and SIT1 are SLC6A18 and
SLC6A20 respectively. Transporters in this subgroup may
play a role in disorders including major depression,
Hartnup disorder, increased susceptibility to myocardial
infarction, and iminoglycinuria. This subgroup belongs
to the solute carrier 6 (SLC6) transporter family.
Length = 565
Score = 77.7 bits (192), Expect = 1e-16
Identities = 30/60 (50%), Positives = 39/60 (65%)
Query: 139 KSEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+ E+ G GL FIV+ AI PG+ FWS++FF+MLLTLGL S FG E ++T L D
Sbjct: 351 EDELDEAVEGTGLAFIVFTEAIVKFPGAPFWSVLFFLMLLTLGLGSMFGTLEGVLTPLFD 410
Score = 69.6 bits (171), Expect = 5e-14
Identities = 46/153 (30%), Positives = 66/153 (43%), Gaps = 37/153 (24%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
ML + GIPLF++ELA+GQ RKG+I W I P G +AS F+ Y
Sbjct: 46 MLVLEGIPLFFLELAIGQRLRKGSIGVWNTISPYLGG-----IGIASCV---VSFLVALY 97
Query: 61 FNGLLSGVL--------------VLTQHLNGNRYILEMQHST---------------GLH 91
+N +++ + NG Y+ E S+ +
Sbjct: 98 YNVIIAWCFFYLFNSFQYPLPWSSCPTNGNGTGYVEECAKSSPTQYFWYRTTLDISPSID 157
Query: 92 DLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+ G + W M LCLL ++I Y M KGI +SGK
Sbjct: 158 ESGGLNWWMTLCLLLAWIIVYLCMIKGIKSSGK 190
>gnl|CDD|212076 cd11507, SLC6sbd_GAT2, Na(+)- and Cl(-)-dependent GABA transporter
2; solute-binding domain. This family includes human
GAT2 (hGAT2) which transports gamma-aminobutyric acid
(GABA). GABA is the main inhibitory neurotransmitter
within the mammalian CNS. hGAT2 is encoded by the
SLC6A13 gene, and is similar to mouse GAT-3, and rat
GAT2. hGAT2 is expressed in brain, kidney, lung, and
testis. hGAT2 is a potential drug target for treatment
of epilepsy. This subgroup belongs to the solute carrier
6 (SLC6) transporter family.
Length = 544
Score = 75.7 bits (186), Expect = 5e-16
Identities = 54/211 (25%), Positives = 90/211 (42%), Gaps = 74/211 (35%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG---------KMTRLARMASLTWPP 52
LF GIP+F++E ALGQ+ +G +TCW +I PLF+G + + L W
Sbjct: 47 LFTCGIPVFFLETALGQYTSQGGVTCWRKICPLFEGIGYASQVIVALLNFYYIIVLAW-- 104
Query: 53 ALF------------------------IDGKYFNGLLSGVLVLTQHLNGNRYILE----- 83
ALF ++ + N ++ L N ++E
Sbjct: 105 ALFYLFNSFTWELPWSSCNHTWNTENCVEFQKRNYSVNVTLE-----NATSPVIEFWERR 159
Query: 84 -MQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK------------------ 124
++ S G+ +G ++W++ALCLL ++ICYF +WKG+ ++GK
Sbjct: 160 VLRISDGIEHIGSLRWELALCLLLAWVICYFCIWKGVKSTGKVVYFTATFPYLMLVVLLI 219
Query: 125 ----------GIKYYLQPNFDAITKSEVSGD 145
GI++YL P+ + +V D
Sbjct: 220 RGVTLPGASLGIQFYLYPDLSRLADPQVWMD 250
Score = 61.8 bits (150), Expect = 3e-11
Identities = 30/59 (50%), Positives = 41/59 (69%), Gaps = 2/59 (3%)
Query: 140 SEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
SEV+ SGPGL FI YP A++ MP S W+ FF+M++ LGLDS F E+++TA+ D
Sbjct: 317 SEVA--ESGPGLAFIAYPRAVSMMPFSPLWACFFFIMIVLLGLDSQFVCVESLVTAMVD 373
>gnl|CDD|212077 cd11508, SLC6sbd_GAT3, Na(+)- and Cl(-)-dependent GABA transporter
3; solute-binding domain. This family includes human
GAT3 (hGAT3) a high-affinity transporter of
gamma-aminobutyric acid (GABA). GABA is the main
inhibitory neurotransmitter within the mammalian CNS.
hGAT3 is encoded by the SLC6A11 gene, and is similar to
mouse GAT4, and rat GAT3/GATB. GAT3 is expressed
primarily in the glia of the brain, and is a potential
drug target for antiepileptic drugs. This subgroup
belongs to the solute carrier 6 (SLC6) transporter
family.
Length = 542
Score = 73.5 bits (180), Expect = 3e-15
Identities = 65/233 (27%), Positives = 103/233 (44%), Gaps = 51/233 (21%)
Query: 1 MLFVG-GIPLFYMELALGQFHRKGAITCWGRIVPLFKG---------KMTRLARMASLTW 50
+ F+ GIP+F++E ALGQF +G ITCW ++ PLF+G + + L W
Sbjct: 46 VFFICCGIPVFFLETALGQFTSEGGITCWRKVCPLFEGIGYATQVIEAHLNVYYIIILAW 105
Query: 51 PPALFIDGKYFNGLLSGVL----------VLTQHLNGNRY-----------ILEMQH--- 86
A+F F L V Q LN + ++E
Sbjct: 106 --AIFYLFNCFTTELPWATCGHEWNTENCVEFQKLNSSNCSHVSLQNATSPVMEFWERRV 163
Query: 87 ---STGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGKGIKYYLQPNFDAITK---- 139
S G+ +G ++W++ALCLLA + ICYF +WKG ++GK + Y+ F I
Sbjct: 164 LAISDGIEHIGNLRWELALCLLAAWTICYFCIWKGTKSTGKVV--YVTATFPYIMLLILL 221
Query: 140 -SEVSGDTSGPGLVFIVYPAAIATMPGSIFW----SLIFFMMLLTLGLDSSFG 187
V+ + G+ F +YP ++ + W + IFF + LG ++ G
Sbjct: 222 IRGVTLPGASEGIKFYLYP-DLSRLSDPQVWVDAGTQIFFSYAICLGCLTALG 273
Score = 63.1 bits (153), Expect = 1e-11
Identities = 33/67 (49%), Positives = 43/67 (64%), Gaps = 2/67 (2%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPRDE 206
SGPGL FI YP A+ MP S W+ +FFMML+ LGLDS F E+++TA+ D P+
Sbjct: 325 SGPGLAFIAYPKAVTMMPLSPLWATLFFMMLIFLGLDSQFVCVESLVTAVVD--MYPKVF 382
Query: 207 LAGFRSE 213
G+R E
Sbjct: 383 RRGYRRE 389
>gnl|CDD|212070 cd11501, SLC6sbd_ATB0, Na(+)- and Cl(-)-dependent beta-alanine
transporter ATB0+; solute-binding domain. ATB0+ (also
known as the beta-alanine carrier) is a transmembrane
transporter with a broad substrate specificity; it can
transport non-alpha-amino acids such as beta-alanine
with low affinity, and can transport dipolar and
cationic amino acids such as leucine and lysine, with a
higher affinity. It may have a role in the absorption of
essential nutrients and drugs in the distal regions of
the human gastrointestinal tract. Human ATB0+ is encoded
by the SLC6A14 gene. ATB0+ is expressed in the lung,
trachea, salivary gland, mammary gland, stomach, and
pituitary gland. ATB0+ may play a role in obesity, and
its upregulation may have a pathogenic role in
colorectal cancer. This subgroup belongs to the solute
carrier 6 (SLC6) transporter family.
Length = 601
Score = 72.5 bits (178), Expect = 6e-15
Identities = 30/52 (57%), Positives = 35/52 (67%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
SG L FI YP A+A +P S WS++FF MLLTLGLDS F G E I T + D
Sbjct: 346 SGFDLAFIAYPEALAKLPISPLWSILFFFMLLTLGLDSQFAGIETITTTIQD 397
Score = 47.5 bits (113), Expect = 2e-06
Identities = 19/37 (51%), Positives = 26/37 (70%), Gaps = 1/37 (2%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
ML + G+PLF++E +LGQF G I+ W R VPL +G
Sbjct: 46 MLALAGLPLFFLECSLGQFASLGPISVW-RAVPLLQG 81
Score = 45.2 bits (107), Expect = 1e-05
Identities = 18/41 (43%), Positives = 29/41 (70%)
Query: 84 MQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+Q S+G+ + G I W +ALCLL ++I +++KGI +SGK
Sbjct: 183 LQRSSGMDETGPIVWYLALCLLLAWIIVGAALFKGIKSSGK 223
>gnl|CDD|212078 cd11509, SLC6sbd_CT1, Na(+)- and Cl(-)-dependent creatine
transporter 1; solute-binding domain. CT1 (also called
CRTR, CRT) transports creatine. Human CT1 is encoded by
the SLC6A8 gene. CT1 is ubiquitously expressed, with
highest levels found in skeletal muscle and kidney.
Creatine is absorbed from food or synthesized from
arginine and plays an important role in energy
metabolism. Deficiency in human CT1 leads to X-linked
cerebral creatine transporter deficiency. In males, this
disorder is characterized by language and speech delays,
autistic-like behavior, seizures in about 50% of cases,
and can also involve midfacial hypoplasia, and short
stature. In females, it is characterized by mild
cognitive impairment with behavior and learning
problems. This subgroup belongs to the solute carrier 6
(SLC6) transporter family.
Length = 592
Score = 72.2 bits (177), Expect = 7e-15
Identities = 58/220 (26%), Positives = 90/220 (40%), Gaps = 81/220 (36%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARM--------------- 45
++FVGGIP+F++E+ALGQF ++G I W I PLF K A M
Sbjct: 46 IVFVGGIPVFFLEIALGQFMKQGGINAWN-IAPLF--KGLGYASMVIVFFCNTYYIMILV 102
Query: 46 -----------ASLTWPPA-----------LFIDGKYFNGLLSGV-------LVLTQHLN 76
+L W +F NG L+ L + N
Sbjct: 103 WGLYYLVHSFTNTLPWATCGHPWNTENCTEIFRHEDCANGSLANSWSQTFLNLSCDELAN 162
Query: 77 GNRYILE------MQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK------ 124
++E ++ S GL + G + W+M LCLLA ++I YF +WKG+ ++GK
Sbjct: 163 KRSPVIEFWENKVLRLSGGLEEPGALNWEMILCLLATWVIVYFCVWKGVKSTGKIVYFTA 222
Query: 125 ----------------------GIKYYLQPNFDAITKSEV 142
GI YYL+P++ + +++V
Sbjct: 223 LFPYVVLIVLLVHGVTLPGALDGIIYYLKPDWSKLGEAQV 262
Score = 67.6 bits (165), Expect = 3e-13
Identities = 33/69 (47%), Positives = 39/69 (56%), Gaps = 2/69 (2%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPRDE 206
SGPGL FI YP A+ MP + W+ +FF MLL LGLDS F G E IT + D P+
Sbjct: 337 SGPGLAFIAYPKAVTLMPVAPLWAALFFFMLLLLGLDSQFVGVEGFITGILD--LFPQKY 394
Query: 207 LAGFRSEAT 215
R E T
Sbjct: 395 YGRLRREIT 403
>gnl|CDD|212079 cd11510, SLC6sbd_TauT, Na(+)- and Cl(-)-dependent taurine
transporter; solute-binding domain. TauT is a Na(+)-
and Cl(-)-dependent, high-affinity, low-capacity
transporter of taurine and beta-alanine. Human TauT is
encoded by the SLC6A6 gene. TauT is expressed in brain,
retina, liver, kidney, heart, spleen, and pancreas. It
may play a part in the supply of taurine to the
intestinal epithelium and in the between-meal-capture of
taurine. It may also participate in re-absorbing taurine
that has been deconjugated from bile acids in the distal
lumen. Functional TauT protects kidney cells from
nephrotoxicity caused by the chemotherapeutic agent
cisplatin; cisplatin down-regulates TauT in a
p53-dependent manner. In mice, TauT has been shown to be
important for the maintenance of skeletal muscle
function and total exercise capacity. TauT-/- mice
develop additional clinically important diseases, some
of which are characterized by apoptosis, including
vision loss, olfactory dysfunction, and chronic liver
disease. This subgroup belongs to the solute carrier 6
(SLC6) transporter family.
Length = 542
Score = 68.3 bits (167), Expect = 2e-13
Identities = 34/67 (50%), Positives = 41/67 (61%), Gaps = 2/67 (2%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPRDE 206
SGPGL FI YP A+ MP FW+++FF+MLL LGLDS F E IT+L D P
Sbjct: 325 SGPGLAFIAYPKAVTMMPLPTFWAILFFIMLLLLGLDSQFVEVEGQITSLVD--LYPSFL 382
Query: 207 LAGFRSE 213
G+R E
Sbjct: 383 RKGYRRE 389
Score = 60.6 bits (147), Expect = 7e-11
Identities = 37/108 (34%), Positives = 59/108 (54%), Gaps = 8/108 (7%)
Query: 87 STGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGKGIKYYLQPNFDAITKSEVSGDT 146
S+G+ +G IKWD+ALCLL V++IC+F +WKG+ ++GK + + F + + G T
Sbjct: 167 SSGIEHVGTIKWDLALCLLLVWVICFFCIWKGVKSTGKVVYFTATFPFLMLIVLLIRGVT 226
Query: 147 ---SGPGLVFIVYPAAIATMPGSIFW----SLIFFMMLLTLGLDSSFG 187
+ G+ F +YP I + W + IFF + LG +S G
Sbjct: 227 LPGAAEGIKFYLYP-DITRLGDPQVWIDAGTQIFFSYAICLGAMTSLG 273
Score = 55.2 bits (133), Expect = 5e-09
Identities = 19/36 (52%), Positives = 29/36 (80%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
LF GG+P+F++E+ALGQ+ +G ITCW ++ P+F G
Sbjct: 47 LFGGGLPVFFLEVALGQYTSEGGITCWEKLCPIFTG 82
>gnl|CDD|212068 cd11499, SLC6sbd_GlyT2, Na(+)- and Cl(-)-dependent glycine
transporter GlyT2; solute-binding domain. GlyT2 (also
called NET1) is a membrane-bound transporter that
re-uptakes glycine from the synaptic cleft. Human GlyT2
is encoded by the SLC6A5 gene. GlyT2 is expressed in
brain and spinal cord. GlyT2 may play a role in pain,
and in spasticity. This subgroup belongs to the solute
carrier 6 (SLC6) transporter family.
Length = 606
Score = 68.1 bits (166), Expect = 2e-13
Identities = 29/51 (56%), Positives = 40/51 (78%)
Query: 148 GPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
GPG+ F+VYP A+ +P S FW++IFF+MLLTLGLD+ F E I+T++SD
Sbjct: 352 GPGIAFVVYPEALTRLPLSPFWAIIFFLMLLTLGLDTMFATIETIVTSVSD 402
Score = 39.2 bits (91), Expect = 0.001
Identities = 18/38 (47%), Positives = 25/38 (65%)
Query: 87 STGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
S G+ G I+W +ALCL ++I Y S+ KGI +SGK
Sbjct: 193 SAGIEYPGEIRWPLALCLFLAWVIVYASLAKGIKSSGK 230
Score = 38.4 bits (89), Expect = 0.002
Identities = 15/37 (40%), Positives = 27/37 (72%), Gaps = 1/37 (2%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
ML + GIP+F++E++LGQF +G ++ W + +P +G
Sbjct: 46 MLALAGIPIFFLEVSLGQFASQGPVSVW-KAIPALQG 81
>gnl|CDD|212086 cd11517, SLC6sbd_B0AT3, glycine transporter, B0AT3; solute-binding
domain. B0AT3 (also called Xtrp2, XT2) transports
glycine. Human B0AT3 is encoded by the SLC6A18 gene.
B0AT3 is expressed in the kidney. Mutations in the
SLC6A18 gene may contribute to the autosomal recessive
disorder iminoglycinuria and its related disorder
hyperglycinuria. SLC6A18 or its neighboring genes are
associated with increased susceptibility to myocardial
infarction. This subgroup belongs to the solute carrier
6 (SLC6) transporter family.
Length = 576
Score = 67.5 bits (165), Expect = 4e-13
Identities = 31/58 (53%), Positives = 39/58 (67%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPR 204
SGPGL FIV+ A+ MPG+ W+++FF ML TLGL S FG E +IT L D +PR
Sbjct: 364 SGPGLAFIVFTEAVLHMPGAQVWAVLFFGMLFTLGLSSMFGNVEGVITPLLDVGVLPR 421
Score = 60.2 bits (146), Expect = 1e-10
Identities = 48/150 (32%), Positives = 69/150 (46%), Gaps = 37/150 (24%)
Query: 6 GIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKYFNGLL 65
GIPLF++ELA+GQ RKG+I W I P G + +T F+ Y+N +L
Sbjct: 52 GIPLFHLELAIGQRLRKGSIGVWTTISPYLGG-----VGLGCVT---VSFLVSLYYNTIL 103
Query: 66 SGVLVLTQH------------LNGNR--YILEMQHSTGLH---------------DLGYI 96
+ VL + L+ NR ++ E Q ST + D G I
Sbjct: 104 AWVLWYFLNSFQHPLPWSSCPLDLNRTGFVEECQGSTAVSYFWYRQTLNITPDINDSGSI 163
Query: 97 KWDMALCLLAVYLICYFSMWKGISTSGKGI 126
+W + LCL A + I Y + +GI T+GK I
Sbjct: 164 QWWLLLCLAACWAIVYLCVIRGIETTGKVI 193
>gnl|CDD|212092 cd11554, SLC6sbd_u2, uncharacterized eukaryotic solute carrier 6
subfamily; solute-binding domain. SLC6 proteins (also
called the sodium- and chloride-dependent
neurotransmitter transporter family or Na+/Cl--dependent
transporter family) include neurotransmitter
transporters (NTTs): these are sodium- and
chloride-dependent plasma membrane transporters for the
monoamine neurotransmitters serotonin
(5-hydroxytryptamine), dopamine, and norepinephrine, and
the amino acid neurotransmitters GABA and glycine. These
NTTs are widely expressed in the mammalian brain, and
are involved in regulating neurotransmitter signaling
and homeostasis, and are the target of a range of
therapeutic drugs for the treatment of psychiatric
diseases. Bacterial members of the SLC6 family include
the LeuT amino acid transporter.
Length = 406
Score = 61.6 bits (150), Expect = 2e-11
Identities = 25/63 (39%), Positives = 37/63 (58%)
Query: 136 AITKSEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITA 195
+T G L F+ YP AIA MPGS F++++FF+ L LG+ S+F EA++T
Sbjct: 246 GMTPGVEGEALGGFVLGFVTYPEAIAQMPGSNFFAVLFFLTLFLLGISSAFALLEAVVTL 305
Query: 196 LSD 198
+ D
Sbjct: 306 ICD 308
Score = 35.4 bits (82), Expect = 0.015
Identities = 14/37 (37%), Positives = 20/37 (54%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
L + IP+ +ELALGQ +R G + + I KG
Sbjct: 45 ALVLLAIPILILELALGQAYRGGCVKAFNLINRRAKG 81
>gnl|CDD|212075 cd11506, SLC6sbd_GAT1, Na(+)- and Cl(-)-dependent GABA transporter
1; solute-binding domain. GAT1 transports
gamma-aminobutyric acid (GABA). GABA is the main
inhibitory neurotransmitter within the mammalian CNS.
Human GAT1 is encoded by the SLC6A1 gene. GAT1 is
expressed in brain and peripheral nervous system. The
antiepileptic drug, Tiagabine, inhibits GAT1. This
subgroup belongs to the solute carrier 6 (SLC6)
transporter family.
Length = 598
Score = 61.1 bits (148), Expect = 4e-11
Identities = 28/52 (53%), Positives = 35/52 (67%)
Query: 147 SGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
SGPGL F+ YP A+ +P S W+++FF MLL LG+DS F E ITAL D
Sbjct: 358 SGPGLAFLAYPEAVTQLPISPLWAVLFFSMLLMLGIDSQFCTVEGFITALVD 409
Score = 48.4 bits (115), Expect = 9e-07
Identities = 46/201 (22%), Positives = 76/201 (37%), Gaps = 56/201 (27%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMA---------SLTWP- 51
L G+PLF +E +LGQ+ G + W ++ P+FKG A ++ + W
Sbjct: 89 LIFAGVPLFLLECSLGQYTSIGGLGVW-KLAPMFKGVGLAAAVLSFWLNIYYIVIIAWAI 147
Query: 52 -----------PALFIDGKYFNGLLSGVLVLTQHLNGNRYILEM------QHSTGLHDLG 94
P D + + N ++E Q + GL G
Sbjct: 148 YYLYNSFTTTLPWKSCDNPWNTDRCFSNYSMANTTNMTSAVVEFWERNMHQMTDGLEKPG 207
Query: 95 YIKWDMALCLLAVYLICYFSMWKGISTSGK----------------------------GI 126
I+W +A+ L +++ YF +WKG+ +GK GI
Sbjct: 208 QIRWPLAITLAIAWVLVYFCIWKGVGWTGKVVYFSATYPYIMLFILFFRGVTLPGAKEGI 267
Query: 127 KYYLQPNFDAITKSEVSGDTS 147
+Y+ PNF ++ SEV D +
Sbjct: 268 LFYITPNFSKLSDSEVWLDAA 288
>gnl|CDD|212087 cd11518, SLC6sbd_SIT1, Na(+)- and Cl(-)-dependent imino acid
transporter SIT1; solute-binding domain. SIT1 (also
called XTRP3, XT3, IMINO) transports imino acids, such
as proline, pipecolate, MeAIB, and sarcosine. It has
weak affinity for neutral amino acids such as
phenylalanine. Human SIT1 is encoded by the SLC6A20
gene. SIT1 is expressed in brain, kidney, small
intestine, thymus, spleen, ovary, and lung. SLC6A20 is a
candidate gene for the rare disorder iminoglycinuria.
This subgroup belongs to the solute carrier 6 (SLC6)
transporter family.
Length = 576
Score = 61.0 bits (148), Expect = 5e-11
Identities = 29/76 (38%), Positives = 43/76 (56%), Gaps = 4/76 (5%)
Query: 139 KSEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+ E+ G GL FIVY AI M S WS+++F MLL LG+ S G + AI+T L+D
Sbjct: 360 EKELDTAVQGTGLAFIVYSEAIKNMEVSQLWSVLYFFMLLMLGIGSMLGNTAAILTPLTD 419
Query: 199 GLA----MPRDELAGF 210
+P++ ++G
Sbjct: 420 SKIISSHLPKEAISGL 435
Score = 52.2 bits (125), Expect = 5e-08
Identities = 42/153 (27%), Positives = 65/153 (42%), Gaps = 37/153 (24%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
ML + G+PL Y+ELA+GQ R+G+I W I P G +AS+ F Y
Sbjct: 49 MLILEGMPLLYLELAVGQRMRQGSIGAWKSISPYLGG-----VGVASVV---VSFFLSMY 100
Query: 61 FNGLLSGVLVLTQH------------LNGNR-----------------YILEMQHSTGLH 91
+N + + H LN NR Y + S +
Sbjct: 101 YNVINAWAFWYLFHSFQDPLPWSVCPLNSNRTGYTEECEKASPTQYFWYRETLNISPSIE 160
Query: 92 DLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+ G I+W+ ALCL+ +L+ Y + +G ++GK
Sbjct: 161 ESGGIQWEQALCLILAWLVVYLCILRGTESTGK 193
>gnl|CDD|212085 cd11516, SLC6sbd_B0AT1, Na(+)-dependent neutral amino acids
transporter, B0AT1; solute-binding domain. B0AT1 (also
called HND) transports neutral amino acids. Human B0AT1
is encoded by the SLC6A19 gene. B0AT1 is expressed
primarily in the kidney and intestine; it requires
collectrin for expression in the kidney, and
angiotensin-converting enzyme 2 for expression in the
intestine. Interaction with these two proteins
implicates B0AT1 in more complex processes such as
glomerular structure, exocytosis, and blood pressure
control. The autosomal recessive disorder, Hartnup
disorder, is caused by mutations in B0AT1. This subgroup
belongs to the solute carrier 6 (SLC6) transporter
family.
Length = 581
Score = 57.6 bits (139), Expect = 7e-10
Identities = 28/66 (42%), Positives = 38/66 (57%)
Query: 139 KSEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+ +S G GL FIV+ AI MP S WS++FF+ML LGL S FG E ++ L D
Sbjct: 355 NNFLSEGVEGTGLAFIVFTEAITKMPLSPLWSVLFFIMLFCLGLSSMFGNMEGVLVPLQD 414
Query: 199 GLAMPR 204
+P+
Sbjct: 415 LKVIPK 420
Score = 56.0 bits (135), Expect = 3e-09
Identities = 46/155 (29%), Positives = 67/155 (43%), Gaps = 37/155 (23%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
+L GIPL ++E A+GQ RKG++ W I P KG +A M F+ Y
Sbjct: 46 LLVFEGIPLLHLEFAIGQRLRKGSVGVWSTIHPTLKG--VGIASMC------VSFLVSLY 97
Query: 61 FNGLLSGVLVL------------TQHLNGNR--YILE---------------MQHSTGLH 91
+N +++ V+ LN NR YI E + ST +
Sbjct: 98 YNTIIAWVMWYFFNSFQEPLPWSQCPLNENRTGYIPECAKSSPVDYFWYRETLNTSTSID 157
Query: 92 DLGYIKWDMALCLLAVYLICYFSMWKGISTSGKGI 126
D G I+W M LCL + + Y +GI T+GK +
Sbjct: 158 DSGGIQWWMVLCLACAWGVLYVCTIRGIETTGKAV 192
>gnl|CDD|212042 cd10334, SLC6sbd_u1, uncharacterized bacterial and archaeal solute
carrier 6 subfamily; solute-binding domain. SLC6
proteins (also called the sodium- and chloride-dependent
neurotransmitter transporter family or Na+/Cl--dependent
transporter family) include neurotransmitter
transporters (NTTs): these are sodium- and
chloride-dependent plasma membrane transporters for the
monoamine neurotransmitters serotonin
(5-hydroxytryptamine), dopamine, and norepinephrine, and
the amino acid neurotransmitters GABA and glycine. These
NTTs are widely expressed in the mammalian brain,
involved in regulating neurotransmitter signaling and
homeostasis, and the target of a range of therapeutic
drugs for the treatment of psychiatric diseases.
Bacterial members of the SLC6 family include the LeuT
amino acid transporter.
Length = 480
Score = 57.1 bits (139), Expect = 9e-10
Identities = 24/61 (39%), Positives = 36/61 (59%), Gaps = 3/61 (4%)
Query: 146 TSGPGLVFIVYPAAIATMP--GSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMP 203
+SG GL F+ +P AI MP G++F ++FF+ L+ GL S E +I+AL D +
Sbjct: 291 SSGIGLAFVAFPKAINLMPPGGALF-GVLFFLSLVFAGLTSLISLVEVVISALQDKFGLS 349
Query: 204 R 204
R
Sbjct: 350 R 350
Score = 37.9 bits (89), Expect = 0.003
Identities = 37/185 (20%), Positives = 64/185 (34%), Gaps = 58/185 (31%)
Query: 2 LFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPAL--FIDGK 59
L GIPL +E LG R A + RI F+ + W L F+
Sbjct: 47 LLTAGIPLLILEYGLGHKFRGSAPLAFRRINKKFE----------WIGWWQVLVAFVIAT 96
Query: 60 YFNGLLSGVLV-----LTQ--------HLNGNRYILEMQHSTGLHDLGYIKWDMALCLLA 106
Y+ +++ L T G+ L++ S G DLG W + + L+
Sbjct: 97 YYAVIIAWALSYLFFSFTLAWGDDPEAFFFGD--FLQL--SDGPFDLGGFVWPILIALVL 152
Query: 107 VYLICYFSMWKGIST-----------------------------SGKGIKYYLQPNFDAI 137
V+LI +F +++G+ + G+ P++ A+
Sbjct: 153 VWLIIWFILYRGVKKGIEKANKIFMPLLFVLFLILVIRALTLPGAADGLNALFTPDWSAL 212
Query: 138 TKSEV 142
+V
Sbjct: 213 LDPKV 217
>gnl|CDD|212084 cd11515, SLC6sbd_NTT4-like, Na(+)-dependent neurotransmitter
transporter 4, and related proteins; solute-binding
domain. This subgroup includes the solute-binding
domain of NTT4 (also called XT1) and SBAT1 (also called
B0AT2, v7-3, NTT7-3); both these proteins can transport
neutral amino acids. Human SBAT1 is encoded by the
SLC6A15 gene, a susceptibility gene for major
depression. SBAT1 is expressed in brain, and may have a
role in transporting neurotransmitter precursors into
neurons. Human NTT4 is encoded by the SLC6A17 gene. NTT4
is specifically expressed in the nervous system, in
synaptic vesicles of glutamatergic and GABAergic
neurons, and may play an important role in synaptic
transmission. This subgroup belongs to the solute
carrier 6 (SLC6) transporter family.
Length = 530
Score = 57.2 bits (138), Expect = 1e-09
Identities = 27/69 (39%), Positives = 39/69 (56%)
Query: 139 KSEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+ E+ G GL FI + A+ P S FWS++FF+ML+ LGL S FG E I T + D
Sbjct: 319 EDELDKAVQGTGLAFIAFTEAMTHFPASPFWSVMFFLMLVNLGLGSMFGTIEGITTPIVD 378
Query: 199 GLAMPRDEL 207
+ ++ L
Sbjct: 379 TFKVRKEIL 387
Score = 49.1 bits (117), Expect = 6e-07
Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 39/155 (25%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
+L V GIPLF++EL++GQ R+G+I W I P +L + + LF+ Y
Sbjct: 46 LLIVIGIPLFFLELSVGQRIRRGSIGVWNYISP-------KLGGIGFASCIVCLFV-ALY 97
Query: 61 FNGLLS-GVLVLTQHL-------------NGNRYILE-----------------MQHSTG 89
+N ++ + +Q N + +E + S+
Sbjct: 98 YNVIIGWSLFYFSQSFQYPLPWDQCPLVKNASHTFVEPECEKSSATTYYWYREALNISSS 157
Query: 90 LHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+ + G + W M +CLLA +++ +M KGI +SGK
Sbjct: 158 ISESGGLNWKMTICLLAAWVMVCLAMIKGIQSSGK 192
>gnl|CDD|212091 cd11522, SLC6sbd_SBAT1, Sodium-coupled branched-chain amino-acid
transporter 1; solute-binding domain. SBAT1 (also
called B0AT2, v7-3, NTT7-3) is a high-affinity
Na(+)-dependent transporter for large neutral amino
acids, including leucine, isoleucine, valine, proline
and methionine. Human SBAT1 is encoded by the SLC6A15
gene, a susceptibility gene for major depression. SBAT1
is expressed in brain, and may have a role in
transporting neurotransmitter precursors into neurons.
This subgroup belongs to the solute carrier 6 (SLC6)
transporter family.
Length = 580
Score = 56.9 bits (137), Expect = 2e-09
Identities = 28/69 (40%), Positives = 41/69 (59%)
Query: 139 KSEVSGDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
+ E++ G GL FI + A+ P S FWS++FF+ML+ LGL S FG E IIT + D
Sbjct: 369 EDELNKAVQGTGLAFIAFTEAMTHFPASPFWSVMFFLMLVNLGLGSMFGTIEGIITPIVD 428
Query: 199 GLAMPRDEL 207
+ ++ L
Sbjct: 429 TFKVRKEIL 437
Score = 40.3 bits (94), Expect = 4e-04
Identities = 18/37 (48%), Positives = 25/37 (67%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG 37
+L V GIPLF++EL++GQ R+G+I W I P G
Sbjct: 46 LLLVIGIPLFFLELSVGQRIRRGSIGVWNYISPKLGG 82
Score = 37.2 bits (86), Expect = 0.005
Identities = 17/43 (39%), Positives = 28/43 (65%), Gaps = 1/43 (2%)
Query: 87 STGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGKGIKYY 129
S+ + + G + W M +CLLA +++ +M KGI +SGK I Y+
Sbjct: 155 SSSISESGGLNWKMTICLLAAWVMVCLAMIKGIQSSGK-IMYF 196
>gnl|CDD|212071 cd11502, SLC6sbd_NTT5, Neurotransmitter transporter 5;
solute-binding domain. Human NTT5 is encoded by the
SLC6A16 gene. NTT5 is expressed in testis, pancreas, and
prostate; its expression is predominantly intracellular,
indicative of a vesicular location. Its substrates are
unknown. This subgroup belongs to the solute carrier 6
(SLC6) transporter family.
Length = 543
Score = 55.9 bits (135), Expect = 3e-09
Identities = 38/153 (24%), Positives = 64/153 (41%), Gaps = 35/153 (22%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
MLF+ GIPL ++E+A+GQ ++G+I W I P F G +S+ A F+ Y
Sbjct: 46 MLFLVGIPLLFLEMAVGQRLQQGSIRVWKAISPWFGG-----VGYSSVL---ACFLVALY 97
Query: 61 FNGLLSGVLV----------------LTQHLNGNRYILEMQH-----------STGLHDL 93
+N + S L L ++ + S + D
Sbjct: 98 YNVVNSWALFYLGHSFQFPLPWEQCPLVKNSSDPECARTTPSGYFWYQKTLKASDRIEDG 157
Query: 94 GYIKWDMALCLLAVYLICYFSMWKGISTSGKGI 126
G + +AL L + + Y +M +G+ ++GK I
Sbjct: 158 GSLVGHLALSLFVAWCLVYVTMIRGLKSTGKSI 190
Score = 48.2 bits (115), Expect = 1e-06
Identities = 23/51 (45%), Positives = 32/51 (62%)
Query: 148 GPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
GPG F+ + AI+ PGS FW+++FF+ LL GL + FG + I T L D
Sbjct: 346 GPGFAFLAFSEAISLAPGSAFWAIVFFLALLLAGLSTMFGIMQGIYTPLQD 396
>gnl|CDD|212067 cd11498, SLC6sbd_GlyT1, Na(+)- and Cl(-)-dependent glycine
transporter GlyT1; solute-binding domain. GlyT1 is a
membrane-bound transporter that re-uptakes glycine from
the synaptic cleft. Human GlyT1 is encoded by the SLC6A9
gene. GlyT1 is expressed in brain, pancreas, uterus,
stomach, spleen, liver, and retina. GlyT1 may play a
role in schizophrenia. This subgroup belongs to the
solute carrier 6 (SLC6) transporter family.
Length = 585
Score = 55.3 bits (133), Expect = 5e-09
Identities = 25/51 (49%), Positives = 34/51 (66%)
Query: 148 GPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSD 198
GPGL F+ YP A+ +P S WSL+FF ML+ LGL + F E ++TA+ D
Sbjct: 354 GPGLAFVAYPEALTLLPISPLWSLLFFFMLILLGLGTQFCLLETLVTAVVD 404
Score = 49.9 bits (119), Expect = 3e-07
Identities = 55/225 (24%), Positives = 86/225 (38%), Gaps = 81/225 (36%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKG---KMTRLARMASLTWPPALFID 57
ML GIPLF+MEL+ GQF +G + W R+ P+FKG M ++ + + + I
Sbjct: 62 MLVFCGIPLFFMELSFGQFASQGCLGVW-RVSPMFKGVGYGMMVVSTYIGIYYNVVICIA 120
Query: 58 GKYF----------------------NGLLSG-------------VLVLTQHLNGN---- 78
YF G+LS V LT+ LN
Sbjct: 121 FYYFFMSMTRVLPWTYCNNPWNTPDCAGVLSTNRSNATFANMSAVVSNLTELLNRTLKRT 180
Query: 79 --------RYILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK------ 124
RY+L + S + + G ++ + CL +L+ + + +G+ +SGK
Sbjct: 181 SPSEEYWRRYVLNI--SDDIGNFGEVRLPLLGCLGVSWLVVFLCLIRGVKSSGKVVYFTA 238
Query: 125 ----------------------GIKYYLQPNFDAITKSEVSGDTS 147
GI YYL P +D I ++V GD +
Sbjct: 239 TFPYVVLTILFIRGITLEGAISGIMYYLTPQWDKILDAKVWGDAA 283
>gnl|CDD|212090 cd11521, SLC6sbd_NTT4, Na(+)-dependent neurotransmitter transporter
4; solute-binding domain. NTT4 (also called XT1)
transports the neutral amino acids, proline, glycine,
leucine, and alanine, and may play an important role in
synaptic transmission. Human NTT4 is encoded by the
SLC6A17 gene. NTT4 is specifically expressed in the
nervous system, in synaptic vesicles of glutamatergic
and GABAergic neurons. This subgroup belongs to the
solute carrier 6 (SLC6) transporter family.
Length = 589
Score = 53.4 bits (128), Expect = 2e-08
Identities = 30/97 (30%), Positives = 49/97 (50%), Gaps = 3/97 (3%)
Query: 112 YFSMWKGISTSGKGIKYYLQPNFDA-ITKSEVSGDTSGPGLVFIVYPAAIATMPGSIFWS 170
Y M++ I T + ++ + DA + + E+ G GL FI + A+ P S FWS
Sbjct: 343 YAEMYRVIMTVKED--HFKELGLDACLLEDELDKSVQGTGLAFIAFTEAMTHFPASPFWS 400
Query: 171 LIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPRDEL 207
++FF+ML+ LGL S G I T + D + ++
Sbjct: 401 VMFFLMLINLGLGSMIGTMSGITTPIIDTFKVRKEVF 437
Score = 51.1 bits (122), Expect = 1e-07
Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 39/155 (25%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALFIDGKY 60
+L + GIPLF++ELA+GQ R+G+I W I P RL + + F+ G Y
Sbjct: 46 LLIIIGIPLFFLELAVGQRIRRGSIGVWNYICP-------RLGGIGYASCLVCFFV-GLY 97
Query: 61 FNGLLS-GVLVLTQHL-------------NGNRYILE-----------------MQHSTG 89
+N ++ + + NG+ ++E + S
Sbjct: 98 YNVIIGWSIFYFFKSFQYPLPWSECPIVRNGSVAVVEAECEKSSATTYFWYREALDISNS 157
Query: 90 LHDLGYIKWDMALCLLAVYLICYFSMWKGISTSGK 124
+ + G + W M LCLL + I +M KGI +SGK
Sbjct: 158 ISESGGLNWKMTLCLLVAWSIVGLAMIKGIQSSGK 192
>gnl|CDD|212043 cd10336, SLC6sbd_Tyt1-Like, solute carrier 6 subfamily,
Fusobacterium nucleatum Tyt1-like; solute-binding
domain. SLC6 proteins (also called the sodium- and
chloride-dependent neurotransmitter transporter family
or Na+/Cl--dependent transporter family) include
neurotransmitter transporters (NTTs): these are sodium-
and chloride-dependent plasma membrane transporters for
the monoamine neurotransmitters serotonin
(5-hydroxytryptamine), dopamine, and norepinephrine, and
the amino acid neurotransmitters GABA and glycine. These
NTTs are widely expressed in the mammalian brain,
involved in regulating neurotransmitter signaling and
homeostasis, and the target of a range of therapeutic
drugs for the treatment of psychiatric diseases.
Bacterial members of the SLC6 family include the LeuT
amino acid transporter. An arrangement of 12
transmembrane (TM) helices appears to be as a common
topological motif for eukaryotic and some prokaryotic
and archaeal NTTs. However, this subfamily which
contains the majority of bacterial members and some
archaeal members, appears to contain only 11 TMs; for
example the functional Fusobacterium nucleatum tyrosine
transporter Tyt1.
Length = 439
Score = 52.4 bits (127), Expect = 4e-08
Identities = 22/59 (37%), Positives = 31/59 (52%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPR 204
+GPGL+FI PA A MPG + ++FF++LL L S+ E + L D R
Sbjct: 277 AAGPGLLFITLPAVFAQMPGGRLFGILFFLLLLFAALTSAISLLEVPVAYLIDEFGWSR 335
>gnl|CDD|223805 COG0733, COG0733, Na+-dependent transporters of the SNF family
[General function prediction only].
Length = 439
Score = 50.7 bits (122), Expect = 2e-07
Identities = 23/59 (38%), Positives = 33/59 (55%)
Query: 146 TSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMPR 204
+ GPGLVFIV PA MP + ++FF++LL L S+ E ++ AL D + R
Sbjct: 281 SQGPGLVFIVLPAVFNQMPLGTLFGILFFLLLLFAALTSAISMLEVLVAALIDKFGISR 339
Score = 29.1 bits (66), Expect = 2.0
Identities = 49/236 (20%), Positives = 79/236 (33%), Gaps = 59/236 (25%)
Query: 1 MLFVGGIPLFYMELALGQFHRKGAITCWGRIVPLFKGKMTRLARMASLTWPPALF--IDG 58
L + GIPL E A+G+ RK A+ + ++ P K + + + + I G
Sbjct: 50 FLLLVGIPLLLAEFAIGRRGRKNAVGAFRKLAPKKKWEWIGWFGVLGGFLILSFYSVIGG 109
Query: 59 ---KYFNGLLSGVLVLTQHLNGNRYILEMQHSTGLHDLGYIKWDMALCLLAVYLICYFSM 115
Y L+G L T + + GL L L+ LI +
Sbjct: 110 WILSYLVKSLTGALPDTGEQFAQ-LFGQTISNPGL-----AVIFHLLFLVLTALIVSRGV 163
Query: 116 WKGISTSGK-------------------------GIKYYLQPNFDAITKSEVSGDTSGPG 150
KGI + K G+K+ +P+F +T +V
Sbjct: 164 KKGIEKANKIMMPLLFVLFIILVIRAVTLPGAMEGLKFLFKPDFSKLTDPKV-------- 215
Query: 151 LVFIVYPAAIATMPGSIFWSLI--FFMML---LTLGLDSSFGGSEAIITALSDGLA 201
+A + G F+SL F +M+ L S S A+ L + L
Sbjct: 216 --------WLAAL-GQAFFSLSLGFGIMITYSSYLSKKSDLVSS-ALSIVLLNTLI 261
>gnl|CDD|212041 cd10333, LeuT-like_sbd, Aquifex aeolicus LeuT and related proteins;
solute binding domain. LeuT is a bacterial amino acid
transporter with specificity for the hydrophobic amino
acids glycine, alanine, methionine, and leucine. This
subgroup belongs to the solute carrier 6 (SLC6)
transporter family; LeuT has been used as a structural
template for understanding fundamental aspects of SLC6
function. It has an arrangement of 12 transmembrane
helices (TMs), which appears to be a common motif for
eukaryotic and some prokaryotic and archaeal SLC6s: an
inverted topology repeat: TMs1-5 and TMs6-10, and
TMs11-12.
Length = 500
Score = 36.5 bits (85), Expect = 0.007
Identities = 18/61 (29%), Positives = 27/61 (44%)
Query: 144 GDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGLAMP 203
GL FI P + MPG F+ ++F +L G+ SS + +I L + L
Sbjct: 294 AKAGTFGLGFIALPNVFSQMPGGQFFGFLWFFLLFFAGITSSIAMLQPLIAFLEEELKWS 353
Query: 204 R 204
R
Sbjct: 354 R 354
>gnl|CDD|237870 PRK14964, PRK14964, DNA polymerase III subunits gamma and tau;
Provisional.
Length = 491
Score = 28.6 bits (64), Expect = 3.0
Identities = 10/29 (34%), Positives = 16/29 (55%), Gaps = 1/29 (3%)
Query: 104 LLAVYLICYFSMWKGI-STSGKGIKYYLQ 131
L +Y ICYFS+ K I G+ + ++
Sbjct: 282 LQIIYEICYFSITKEIDFLLGEDLITRIK 310
>gnl|CDD|200463 cd11324, AmyAc_Amylosucrase, Alpha amylase catalytic domain found
in Amylosucrase. Amylosucrase is a glucosyltransferase
that catalyzes the transfer of a D-glucopyranosyl moiety
from sucrose onto an acceptor molecule. When the
acceptor is another saccharide, only alpha-1,4 linkages
are produced. Unlike most amylopolysaccharide synthases,
it does not require any alpha-D-glucosyl nucleoside
diphosphate substrate. In the presence of glycogen it
catalyzes the transfer of a D-glucose moiety onto a
glycogen branch, but in its absence, it hydrolyzes
sucrose and synthesizes polymers, smaller
maltosaccharides, and sucrose isoforms. The
Alpha-amylase family comprises the largest family of
glycoside hydrolases (GH), with the majority of enzymes
acting on starch, glycogen, and related oligo- and
polysaccharides. These proteins catalyze the
transformation of alpha-1,4 and alpha-1,6 glucosidic
linkages with retention of the anomeric center. The
protein is described as having 3 domains: A, B, C. A is
a (beta/alpha) 8-barrel; B is a loop between the beta 3
strand and alpha 3 helix of A; C is the C-terminal
extension characterized by a Greek key. The majority of
the enzymes have an active site cleft found between
domains A and B where a triad of catalytic residues
(Asp, Glu and Asp) performs catalysis. Other members of
this family have lost the catalytic activity as in the
case of the human 4F2hc, or only have 2 residues that
serve as the catalytic nucleophile and the acid/base,
such as Thermus A4 beta-galactosidase with 2 Glu
residues (GH42) and human alpha-galactosidase with 2 Asp
residues (GH31). The family members are quite extensive
and include: alpha amylase, maltosyltransferase,
cyclodextrin glycotransferase, maltogenic amylase,
neopullulanase, isoamylase, 1,4-alpha-D-glucan
maltotetrahydrolase, 4-alpha-glucotransferase,
oligo-1,6-glucosidase, amylosucrase, sucrose
phosphorylase, and amylomaltase.
Length = 536
Score = 27.9 bits (63), Expect = 4.5
Identities = 11/18 (61%), Positives = 12/18 (66%), Gaps = 2/18 (11%)
Query: 1 MLFVGGIPLFYM--ELAL 16
+L GGIPL YM EL L
Sbjct: 460 ILSFGGIPLIYMGDELGL 477
>gnl|CDD|238752 cd01475, vWA_Matrilin, VWA_Matrilin: In cartilaginous plate,
extracellular matrix molecules mediate cell-matrix and
matrix-matrix interactions thereby providing tissue
integrity. Some members of the matrilin family are
expressed specifically in developing cartilage
rudiments. The matrilin family consists of at least
four members. All the members of the matrilin family
contain VWA domains, EGF-like domains and a heptad
repeat coiled-coiled domain at the carboxy terminus
which is responsible for the oligomerization of the
matrilins. The VWA domains have been shown to be
essential for matrilin network formation by interacting
with matrix ligands.
Length = 224
Score = 27.3 bits (61), Expect = 5.6
Identities = 12/32 (37%), Positives = 15/32 (46%), Gaps = 1/32 (3%)
Query: 13 ELALGQFHRKGAIT-CWGRIVPLFKGKMTRLA 43
E LG+F K + R+ L G MT LA
Sbjct: 55 EFPLGRFKSKADLKRAVRRMEYLETGTMTGLA 86
>gnl|CDD|233771 TIGR02189, GlrX-like_plant, Glutaredoxin-like family. This
family of glutaredoxin-like proteins is aparrently
limited to plants. Multiple isoforms are found in A.
thaliana and O.sativa.
Length = 99
Score = 26.3 bits (58), Expect = 5.9
Identities = 12/36 (33%), Positives = 20/36 (55%), Gaps = 3/36 (8%)
Query: 42 LARMASLTWPPALFIDGKYFNGLLSGVLVLTQHLNG 77
L+R+ PA+F+ GK GL + V+ H++G
Sbjct: 53 LSRLGCSPAVPAVFVGGKLVGGLEN---VMALHISG 85
>gnl|CDD|235400 PRK05305, PRK05305, phosphatidylserine decarboxylase; Provisional.
Length = 206
Score = 27.1 bits (61), Expect = 6.1
Identities = 11/32 (34%), Positives = 17/32 (53%)
Query: 150 GLVFIVYPAAIATMPGSIFWSLIFFMMLLTLG 181
G FI A + + G ++W L + +LLTL
Sbjct: 6 GYPFIAAAALVLLILGLLWWPLAWIGLLLTLF 37
>gnl|CDD|132844 cd07205, Pat_PNPLA6_PNPLA7_NTE1_like, Patatin-like phospholipase
domain containing protein 6, protein 7, and fungal
NTE1. Patatin-like phospholipase domain containing
protein 6 (PNPLA6) and protein 7 (PNPLA7) are included
in this family. PNPLA6 is commonly known as Neuropathy
Target Esterase (NTE). NTE has at least two functional
domains: the N-terminal domain putatively regulatory
domain and the C-terminal catalytic domain which shows
esterase activity. NTE shows phospholipase activity for
lysophosphatidylcholine (LPC) and phosphatidylcholine
(PC). Exposure of NTE to organophosphates leads to
organophosphate-induced delayed neurotoxicity (OPIDN).
OPIDN is a progressive neurological condition that is
characterized by weakness, paralysis, pain, and
paresthesia. PNPLA7 is an insulin-regulated
phospholipase that is homologus to Neuropathy Target
Esterase (NTE or PNPLA6) and is also known as
NTE-related esterase (NRE). Human NRE is predominantly
expressed in prostate, white adipose, and pancreatic
tissue. NRE hydrolyzes sn-1 esters in
lysophosphatidylcholine and lysophosphatidic acid, but
shows no lipase activity with substrates like
triacylglycerols (TG), cholesteryl esters, retinyl
esters (RE), phosphatidylcholine (PC), or
monoacylglycerol (MG). This family includes subfamily
of PNPLA6 (NTE) and PNPLA7 (NRE)-like phospholipases.
Length = 175
Score = 26.7 bits (60), Expect = 6.6
Identities = 12/39 (30%), Positives = 16/39 (41%)
Query: 28 WGRIVPLFKGKMTRLARMASLTWPPALFIDGKYFNGLLS 66
I K + T L ++ LT P A + G F LL
Sbjct: 51 PEEIEERAKLRSTDLKALSDLTIPTAGLLRGDKFLELLD 89
>gnl|CDD|177117 MTH00042, ND3, NADH dehydrogenase subunit 3; Validated.
Length = 116
Score = 26.1 bits (58), Expect = 7.2
Identities = 11/32 (34%), Positives = 21/32 (65%)
Query: 151 LVFIVYPAAIATMPGSIFWSLIFFMMLLTLGL 182
L+F + PA + T P ++ + F+++LT+GL
Sbjct: 72 LLFPLPPATLITNPSTLLPISLIFLIILTIGL 103
>gnl|CDD|212031 cd06857, SLC5-6-like_sbd, Solute carrier families 5 and 6-like;
solute binding domain. This superfamily includes the
solute-binding domain of SLC5 proteins (also called the
sodium/glucose cotransporters or solute sodium
symporters), SLC6 proteins (also called the sodium- and
chloride-dependent neurotransmitter transporters or
Na+/Cl--dependent transporters), and
nucleobase-cation-symport-1 (NCS1) transporters. SLC5s
co-transport Na+ with sugars, amino acids, inorganic
ions or vitamins. SLC6s include Na+/Cl--dependent plasma
membrane transporters for the monoamine
neurotransmitters serotonin, dopamine, and
norepinephrine, and the amino acid neurotransmitters
GABA and glycine. NCS1s are essential components of
salvage pathways for nucleobases and related
metabolites; their known substrates include allantoin,
uracil, thiamine, and nicotinamide riboside. Members of
this superfamily are important in human physiology and
disease. They contain a functional core of 10
transmembrane helices (TMs): an inverted structural
repeat, TMs1-5 and TMs6-10; TMs numbered to conform to
the SLC6 Aquifex aeolicus LeuT.
Length = 413
Score = 27.2 bits (60), Expect = 8.2
Identities = 11/57 (19%), Positives = 19/57 (33%)
Query: 144 GDTSGPGLVFIVYPAAIATMPGSIFWSLIFFMMLLTLGLDSSFGGSEAIITALSDGL 200
G+ YP +PGS+ + F L + S + T L+ +
Sbjct: 262 GNLPSAANADKAYPWLTQFLPGSVGVKGLVFAALAAAIVSSLAAMLNSTATILTMDI 318
Database: CDD.v3.10
Posted date: Mar 20, 2013 7:55 AM
Number of letters in database: 10,937,602
Number of sequences in database: 44,354
Lambda K H
0.326 0.142 0.448
Gapped
Lambda K H
0.267 0.0729 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Sequences: 44354
Number of Hits to DB: 11,430,211
Number of extensions: 1098282
Number of successful extensions: 1608
Number of sequences better than 10.0: 1
Number of HSP's gapped: 1592
Number of HSP's successfully gapped: 142
Length of query: 218
Length of database: 10,937,602
Length adjustment: 93
Effective length of query: 125
Effective length of database: 6,812,680
Effective search space: 851585000
Effective search space used: 851585000
Neighboring words threshold: 11
Window for multiple hits: 40
X1: 15 ( 7.1 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 40 (21.7 bits)
S2: 57 (25.7 bits)